Expression of cyclooxygenase-2 in eutopic endometrium and ovarian endometriotic tissue in women with severe endometriosis

Gynecologic and Obstetric Investigation

Volumn 69, Issue 2, 2010, Pages 93-100

  Cho, Sihyun ^a   Park, Soo Hyeon ^b   Choi, Young Sik ^c   Seo, Seok Kyo ^a   Kim, Hye Yeon ^a   Park, Ki Hyun ^c   Cho, Dong Jae ^c   Lee, Byung Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Bundang Jeil Women's Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Endometriosis; Reverse transcriptase polymerase chain reaction

Indexed keywords

CA 125 ANTIGEN; CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; GYNECOLOGIC DISEASE; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; OVARY CYST; PRIORITY JOURNAL; SECRETORY PHASE; TUMOR VOLUME;

ADULT; CA-125 ANTIGEN; CYCLOOXYGENASE 2; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; OVARIAN DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 73649145191     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000261017     Document Type: Article

References (24)

1. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 1993; 328: 1759-1769.
2. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-469.
3. Halme J, Becker S, Hammond MG, Raj MH, Raj S: Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol 1983; 145: 333-337.
4. Berkkanoglu M, Arici A: Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59.
5. Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns A, Putman M, Sasano H: Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 1999; 6: 293-301.
6. Tsai SJ, Wu MH, Lin CC, Sun HS, Chen HM: Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 2001; 86: 5765-5773.
7. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE: Prostaglandin e2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997; 82: 600-606.
8. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 33157-33160.
9. Herschman HR: Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994; 13: 241-256.
10. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801.
11. Jones RL, Kelly RW, Critchley HO: Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 1997; 12: 1300-1306.
12. Attar E, Bulun SE: Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update 2006; 12: 49-56.
13. Ota H, Igarashi S, Sasaki M, Tanaka T: Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001; 16: 561-566.
14. Fagotti A, Ferrandina G, Fanfani F, Legge F, Lauriola L, Gessi M, Castelli P, Barbieri F, Minelli L, Scambia G: Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. Hum Reprod 2004; 19: 393-397.
15. Matsuzaki S, Canis M, Pouly JL, Wattiez A, Okamura K, Mage G: Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium. Fertil Steril 2004; 82: 1309-1315.
16. Fanfani F, Fagotti A, Ferrandina G, Bifulco G, Legge F, Lorusso D, Minelli L, Scambia G: Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis. Hum Reprod 2005; 20: 2964-2968.
17. Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M, Meresman G: Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 2008; 23: 2701-2708.
18. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-821.
19. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002; 48: 50-56.
20. Hastings JM, Fazleabas AT: A baboon model for endometriosis: Implications for fertility. Reprod Biol Endocrinol 2006; 4(suppl 1):S7.
21. Raspollini MR, Amunni G, Villanucci A, Boddi V, Taddei GL: COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemotherapy in ovarian cancer. Acta Obstet Gynecol Scand 2006; 85: 493-498.
22. Banu SK, Lee J, Speights VO Jr, Starzinski-Powitz A, Arosh JA: Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 2008; 149: 1180-1189.
23. Ceyhan ST, Onguru O, Baser I, Gunhan O: Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertil Steril 2008; 90: 988-993.
24. Yuan L, Shen F, Lu Y, Liu X, Guo SW: Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil Steril 2009; 91(suppl 4):1303-1306.